Skip to main content
Have a personal or library account? Click to login
Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy Cover

Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy

Open Access
|Jul 2026

Authors

Yi-Lun Wang

g987669@gmail.com

Divisions of Hematology/Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University, Taoyuan, Taiwan

Wan-Ju Lee

Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan

Tang-Her Jaing

Divisions of Hematology/Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University, Taoyuan, Taiwan
DOI: https://doi.org/10.2478/fco-2024-0029 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Submitted on: May 10, 2025
Accepted on: Dec 8, 2025
Published on: Jul 14, 2026
In partnership with: Paradigm Publishing Services

© 2026 Yi-Lun Wang, Wan-Ju Lee, Tang-Her Jaing, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT